ARB
AltShares Merger Arbitrage ETF
NAV as of
4 Week: 25.92 - 26.21
52 Week: 24.71 - 27.27
Latest Closing Price
26.21
Premium / Discount
0.06
Expense Ratio
0.76%
Investment Objective
The investment seeks to provide investment results that closely correspond, before fees and expenses, to the performance of its underlying index, the Water Island Merger Arbitrage USD Hedged Index. The fund seeks to track the performance of the index, which is designed to reflect a global merger arbitrage strategy. Under normal market conditions, it will invest at least 80% of its net assets (including borrowings for investment purposes) in the constituents of the index and in financial instruments with economic characteristics similar to such constituents such as swaps on such constituents. The fund is non-diversified.
Main Fund Characteristics
Performance
Period | Performance Returns(%) | Volatility(%) | Risk Adjusted Performance |
---|---|---|---|
YTD | 1.75 | 0.35 | 4.98 |
1 Day | 0.23 | 0.00 | 0.00 |
1 Week | 0.19 | 0.33 | 0.56 |
1 Month | 1.39 | 0.70 | 2.00 |
3 Months | 3.86 | 1.31 | 2.94 |
6 Months | 5.03 | 4.19 | 1.20 |
1 Year | -2.60 | 6.81 | -0.38 |
2 Years | 1.63 | 9.29 | 0.18 |
3 Years | 3.09 | 10.46 | 0.30 |
5 Years | 0.00 | 0.00 | 0.00 |
10 Years | 0.00 | 0.00 | 0.00 |
Price History
Annual Performance Return
2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | |
Price (%) | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 3.1991 | 2.5939 |
Nav (%) | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 |
Rank | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 52.0000 | 18.0000 |
Dividend Frequency
Lastest Dividend
Ex Date | Payment Date | Dividend Payout per unit |
---|---|---|
N.A |
Portfolio Data
Total Number of Holdings: 81
Number of Bond Holdings: 0
Number of Equity Holdings: 52
Total Market Value: 67,273,358
Portfolio Composition
Top 10 Holdings
% Portfolio Weight | Shares Owned | Shares Changed | Market Value | ||
---|---|---|---|---|---|
1 | Prometheus Biosciences Inc | 3.7264 | 11,253 | 11,253 | 2,235,971 |
2 | IVERIC bio Inc | 3.6736 | 58,393 | 58,393 | 2,204,336 |
Country Exposure
Regional Exposure
America
Greater Europe
Greater Asia
Market Classification
Market Capitalization
Size | % of portfolio |
---|---|
Giant | 0.00 |
Large | 2.60 |
Medium | 29.82 |
Small | 34.67 |
Micro | 25.90 |
Equity Style Box Breakdown
0 | 0 | 0 | Large |
0 | 0 | 0 | Mid |
0 | 0 | 0 | Small |
Value | Blend | Growth |
Value Measures
Price/Prospective Earnings*
13.2862
Price/Book*
2.6411
Price/Sales*
0.8608
Price/Cash Flow*
7.3652
Dividend Yield*
1.8407
Growth Measures
Long-Term Earnings
16.0529
Historical Earnings
13.5852
Sales Growth
14.3610
Cash-Flow Growth
6.2963
Book-Value Growth
4.8105
*Forward-looking based on historical data.
Equity Sector
Number of Bond Holdings
0
Bond Statitics
Detail | Value |
---|---|
Average Effective Duration | 0 |
Average Effective Maturity (Years)* | 0 |
Average Credit Quality | 0 |
Average Weighted Coupon* | 0 |
Average Weighted Price* | 0 |
Bond Style Box Breakdown
0 | 0 | 0 | High | Quality |
0 | 0 | 0 | Med | |
0 | 0 | 0 | Low | |
Ltd | Mod | Ext | ||
Interest-Rate Sensitivity |
Credit Quality
Type | % Bonds |
---|---|
N.A |
Bond Sector
Bond Maturity
% Bonds | |
---|---|
N.A |
Data Source: Morningstar
© 2019 Morningstar. All Rights Reserved. The information, data, analyses and opinions (“Information”) contained herein:
(2) may not be copied or redistributed except as specifically authorised;
(3) do not constitute investment advice;
(4) are provided solely for informational purposes;
(5) are not warranted to be complete, accurate or timely; and
(6) may be drawn from fund data published on various dates.
Morningstar and Phillip Securities Pte Ltd are not responsible for any trading decisions, damages or other losses related to the Information or its use. Please verify all of the Information before using it and don’t make any investment decision except upon the advice of a professional financial adviser. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up.
For the most up-to-date fund’s data and information, a copy of the fund factsheet, information or prospectus may be obtained from the respective ETF issuer.